Pacira BioSciences, Inc. (NASDAQ: PCRX)
$18.5900
+0.0100 ( +0.22% ) 394.4K
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
Market Data
Open
$18.5900
Previous close
$18.5800
Volume
394.4K
Market cap
$857.90M
Day range
$18.1960 - $18.8510
52 week range
$11.1640 - $34.7800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Sep 27, 2024 |
4 | Insider transactions | 1 | Sep 13, 2024 |
8-k | 8K-related | 13 | Sep 09, 2024 |
4 | Insider transactions | 1 | Aug 19, 2024 |
4 | Insider transactions | 1 | Aug 19, 2024 |
4 | Insider transactions | 1 | Aug 14, 2024 |
4/a | Other | 1 | Aug 13, 2024 |
4 | Insider transactions | 1 | Aug 13, 2024 |
4 | Insider transactions | 1 | Aug 12, 2024 |
4 | Insider transactions | 1 | Aug 12, 2024 |